TABLE 2.
Terminals Labeled After Tracer Injection Into a Specific Auditory Nucleus1
Case No. | Injection site | iNL | cNL | iNA | cNA | iSOd | iSOv | cSOd | cSOv |
---|---|---|---|---|---|---|---|---|---|
39 | NM | + | ++ | ||||||
107 | NM/NL | ++ | ++ | ++ | + | + | |||
157 | NM/NL | +++ | ++ | +++ | |||||
108 | NA | + | + | ||||||
149 | NA | ++ | + | + | + | ||||
163 | SOd | +++ | |||||||
165 | SOd | ++ | ++ | ||||||
159 | SOd | ++ | ++ | ||||||
71 | TS | + | |||||||
78 | TS | ++ | ++ | ||||||
80 | TS | + | ++++ | ++ | ++ | ||||
137 | TS | ||||||||
156 | TS |
+, 1–10; ++, 11–100; +++, 101–500; ++++, 501–2,000; +++++, >2,000. Differences in the number of labeled terminals may reflect differences in the size of the injection site. Terminals were manually counted in Neurolucida software.